KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 126 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,334,416 | +10.1% | 76,823 | -10.8% | 0.03% | +3.1% |
Q2 2023 | $1,212,232 | +180.3% | 86,096 | +114.2% | 0.03% | +166.7% |
Q1 2023 | $432,530 | -55.8% | 40,198 | -38.5% | 0.01% | -57.1% |
Q4 2022 | $979,422 | +34.4% | 65,382 | +15.1% | 0.03% | +7.7% |
Q3 2022 | $729,000 | – | 56,810 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |